Drug Type Small molecule drug |
Synonyms AM-36, CNSB-002 |
Target |
Action modulators |
Mechanism σ1 receptor modulators(Sigma opioid receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H39ClN2O2 |
InChIKeyZGSFWANJADAZQC-UHFFFAOYSA-N |
CAS Registry199467-52-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stroke | Preclinical | United Kingdom | 01 Nov 2000 | |
Alzheimer Disease | Discovery | Australia | - | |
Brain Injuries | Discovery | Australia | - | |
Neuralgia | Discovery | Australia | - |